Last reviewed · How we verify
NCT04697706
Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease
EARLY_PHASE1 trial testing Moonstone in Urinary Stone in 6 participants. Completed in 14 December 2020.
14 December 2020
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 1 September 2020 |
| Primary completion | 14 December 2020 |
| Estimated completion | 14 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Moonstone
- Water (WATER) — full drug profile →
Conditions studied
- Urinary Stone — all drugs for Urinary Stone →
Sponsor
NYU Langone Health — full company profile →
Who can join
18 and older, any sex, with Urinary Stone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will investigate the effect of a patented high citrate beverage on urine chemistry in patients with urinary stone disease (USD). It is a minimal risk study of an over-the-counter beverage called Moonstone, which is commercially available. This study is considered preparatory for the RO-1 and is not intended to produce a definitive outcome regarding kidney stones.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04697706
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Stone
Currently open trials in the same condition.
- NCT06628765 — Two Types of Single-use Flexible Ureteroscopies for the Treatment of Upper Urinary Tract Stones in Children · NA · recruiting
- NCT06412900 — Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence · active not recruiting
- NCT04796792 — Ultrasound to Facilitate Stone Passage · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04697706 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 6 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04697706.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing